Test Story

By: NewsUSA

March 27, 2025 at 20:00 PM EDT

(NewsUSA) - For more details, including important safety information, on VenaSeal, visit: https://www.medtronic.com/breakfree.

Sources

Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: Clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011;53(5 Suppl):2S–48S. doi: 10.1016/j.jvs.2011.01.079.

Mayo Clinic: Varicose Veinshttps://www.mayoclinic.org/diseases-conditions/varicose-veins/symptoms-causes/syc-20350643

National Heart Lung and Blood Institute: Varicose Veins https://www.nhlbi.nih.gov/health/varicose-veins

Morrison N, Gibson K, McEnroe S, et al. Randomized trial comparing cyanoacrylate embolization and radiofrequency ablation for incompetent great saphenous veins (VeClose). J Vasc Surg. 2015;61(4):985–994. doi: 10.1016/j.jvs.2014.11.071.

Proebstle T, Alm J, Dimitri S, et al. Three-year follow-up results of the prospective European multicenter cohort study on cyanoacrylate embolization for treatment of refluxing great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2021;9(2):329–334. doi: 10.1016/j.jvsv.2020.05.019.

Almeida JI, Javier JJ, Mackay EG, Bautista C, Cher DJ, Proebstle TM. Thirty-sixth-month follow-up of first-in-human use of cyanoacrylate adhesive for treatment of saphenous vein incompetence. J Vasc Surg Venous Lymphat Disord. 2017;5(5):658–666. doi: 10.1016/j.jvsv.2017.03.016.

Symbol	Price	Change (%)
AMZN	229.67	+3.39 (1.50%)
AAPL	276.97	+1.05 (0.38%)
AMD	206.13	-8.92 (-4.15%)
BAC	52.48	+0.55 (1.06%)
GOOG	323.64	+5.17 (1.62%)
META	636.22	+23.17 (3.78%)
MSFT	476.99	+2.99 (0.63%)
NVDA	177.82	-4.73 (-2.59%)
ORCL	197.03	-3.25 (-1.62%)
TSLA	419.40	+1.62 (0.39%)

Symbol

Price

Change (%)

AMZN

229.67

+3.39 (1.50%)

AAPL

276.97

+1.05 (0.38%)

AMD

206.13

-8.92 (-4.15%)

BAC

52.48

+0.55 (1.06%)

GOOG

323.64

+5.17 (1.62%)

Test Story

More News

Recent Quotes

Starting at $3.75/week.

Subscribe Today